← Evidence map

ReviewThe oncologist2026

Shifting a paradigm: highlights of model informed drug development in dosage selection and optimization for oncology products.

Ye Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42082405